<DOC>
	<DOCNO>NCT00077064</DOCNO>
	<brief_summary>RATIONALE : Captopril drug may able decrease side effect cause radiation therapy , may improve quality life patient non-small cell lung cancer limited-stage small cell lung cancer . PURPOSE : This randomized phase II trial study well captopril work decrease side effect improve quality life patient receive radiation therapy without chemotherapy stage I , stage II , stage IIIB non-small cell lung cancer limited-stage small cell lung cancer .</brief_summary>
	<brief_title>Captopril Treating Patients With Non-Small Cell Lung Cancer Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With Without Chemotherapy</brief_title>
	<detailed_description>OBJECTIVES : - Determine effect captopril incidence pulmonary damage 12 month radiotherapy without chemotherapy patient stage II-IIIB non-small cell lung cancer , stage I central non-small cell lung cancer , limited stage small cell lung cancer . - Compare quality life patient treat captopril v patient undergo post-radiotherapy observation . - Determine persistence captopril 's effect pulmonary toxicity patient . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center , total lung irradiate ( &lt; 25 % vs 25-37 % vs 37 % ) , prior surgery ( yes v ) , prior chemotherapy ( yes v ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral captopril 3 time daily 1 year absence disease progression unacceptable toxicity . - Arm II : Patients undergo observation 1 year . Quality life assess baseline month 3 , 6 , 12 , 18 . Patients follow every 3 month 1 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : A total 205 patient accrue study within 18 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Radiation Pneumonitis</mesh_term>
	<mesh_term>Captopril</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : One follow histologically cytologically confirm diagnosis : Stage IIIIIB nonsmall cell lung cancer ( NSCLC ) Stage I central NSCLC No peripheral coin lesion Limited stage small cell lung cancer Nonmetastatic disease receive radiotherapy target confine single radiotherapy treatment area Planning receive radiotherapy At least 45 Gy deliver target volume More 25 % total lung volume receive &gt; 20 Gy receive radiotherapy alone PATIENT CHARACTERISTICS : Age 18 Performance status Zubrod 01 Hematopoietic Absolute granulocyte count great 1,000/mm^3 Platelet count great 75,000/mm^3 Hemoglobin great 9.0 g/dL ( transfusion allow ) Hepatic Bilirubin le 1.5 mg/dL Serum glutamate oxaloacetate transaminase ( SGOT ) less 2 time normal Renal Blood urea nitrogen ( BUN ) less 25 mg/dL Creatinine le 1.6 mg/dL Urine protein le 10 mg/dL Urine glucose negative Cardiovascular Systolic blood pressure great 110 mm Hg Diastolic blood pressure great 60 mm Hg Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Sodium normal Potassium normal No collagen vascular disease ( e.g. , lupus scleroderma ) Rheumatoid arthritis allow No known hypersensitivity ACE inhibitor PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Induction concurrent chemotherapy allow either radiotherapy therapy captopril No concurrent methotrexate Endocrine therapy Not specify Radiotherapy See Disease Characteristics Surgery Prior pulmonary lobectomy segmentectomy allow No prior pneumonectomy Other No concurrent angiotensinconverting enzyme ( ACE ) inhibitor angiotensin II receptor antagonist hypertension congestive heart failure No concurrent lithium No concurrent procainamide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>radiation fibrosis</keyword>
	<keyword>pulmonary complication</keyword>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage I non-small cell lung cancer</keyword>
</DOC>